kainic acid has been researched along with Retinal Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, ML; Kalloniatis, M; Khoo, P; Nivison-Smith, L | 1 |
| Agrawal, A; Cohen, ED; Hammer, DX; Hanig, JP; Langsner, RJ; Li, Y; Majdi, JA; Qian, H; Shea, KI | 1 |
| Gao, S; Ho, G; Kng, YL; Kumar, S; Loh, MY; Min, XS; Zhuo, L | 1 |
| Ali, SA; Hosaka, YZ; Uehara, M | 1 |
| Bergamini, C; Capaccioli, S; Dal Monte, M; Lulli, M; Papucci, L; Schipani, C; Torre, E; Witort, E | 1 |
| Bonne, C; D'Aldin, C; Maurin, L; Muller, A; Payet, O | 1 |
| Hara, A; Kozawa, O; Kumada, M; Matsuno, H; Matsuo, O; Mori, H; Niwa, M; Wang, X; Yamamoto, T | 1 |
| Cheon, EW; Cho, CH; Cho, GJ; Choi, WS; Chung, YC; Kim, YS; Kwon, JG; Park, CH; Yoo, JM | 1 |
| Casson, RJ; Chidlow, G; Manavis, J; Osborne, NN; Wood, JP | 1 |
9 other study(ies) available for kainic acid and Retinal Diseases
| Article | Year |
|---|---|
Vinpocetine protects inner retinal neurons with functional NMDA glutamate receptors against retinal ischemia.
Topics: Animals; Calbindin 2; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Ischemia; Kainic Acid; Neuroprotective Agents; Parvalbumins; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Retinal Diseases; Retinal Neurons; Retinal Vessels; Vinca Alkaloids | 2018 |
The use of time-lapse optical coherence tomography to image the effects of microapplied toxins on the retina.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Kainic Acid; Male; Rabbits; Retinal Diseases; Retinal Photoreceptor Cell Outer Segment; Retinal Pigment Epithelium; Time Factors; Tomography, Optical Coherence | 2014 |
Molecular imaging of retinal gliosis in transgenic mice induced by kainic acid neurotoxicity.
Topics: Animals; Brain Diseases; Diagnostic Imaging; Disease Models, Animal; Excitatory Amino Acid Agonists; Fluorescence; Glial Fibrillary Acidic Protein; Gliosis; Green Fluorescent Proteins; Immunohistochemistry; Injections, Intraperitoneal; Kainic Acid; Mice; Mice, Transgenic; Neurotoxicity Syndromes; Ophthalmoscopes; Optic Nerve; Retinal Diseases | 2009 |
Expression of small leucine-rich proteoglycans in the developing retina and kainic acid-induced retinopathy in ICR mice.
Topics: Animals; Biological Transport; Gene Expression Regulation, Developmental; Kainic Acid; Mice; Mice, Inbred ICR; Proteoglycans; Retina; Retinal Diseases | 2011 |
Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage.
Topics: Administration, Topical; Animals; Antimycin A; Apoptosis; Caspase 3; Caspase 7; Cell Count; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Cornea; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Glutamic Acid; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Mitochondria; Ophthalmic Solutions; Rabbits; Rats; Rats, Wistar; Retina; Retinal Diseases; Retinal Ganglion Cells; Time Factors; Ubiquinone; Vitamins | 2012 |
Anti-excitotoxic activity of trimetazidine in the retina.
Topics: Administration, Oral; Animals; Cell Line; Disease Models, Animal; Electroretinography; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Guinea Pigs; Ischemia; Kainic Acid; Rats; Rats, Wistar; Retina; Retinal Diseases; Trimetazidine | 2004 |
Endogenous tissue type plasminogen activator facilitates NMDA-induced retinal damage.
Topics: Animals; Cell Count; DNA Fragmentation; Excitatory Amino Acid Agonists; Glutamates; In Situ Nick-End Labeling; Injections; Kainic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methylaspartate; Neurons; Plasminogen Inactivators; Recombinant Proteins; Reperfusion Injury; Retina; Retinal Diseases; Retinal Ganglion Cells | 2004 |
Protective effects of betaxolol in eyes with kainic acid-induced neuronal death.
Topics: Analysis of Variance; Animals; Betaxolol; Cell Count; Cell Death; Choline O-Acetyltransferase; Disease Models, Animal; Drug Administration Routes; Drug Administration Schedule; Immunohistochemistry; Kainic Acid; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries.
Topics: Animals; Excitatory Amino Acid Agonists; Fluorescent Antibody Technique, Indirect; Immunoenzyme Techniques; Kainic Acid; N-Methylaspartate; Osteopontin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retina; Retinal Diseases; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thy-1 Antigens; Transcription Factor Brn-3 | 2008 |